#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12064	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2117	563.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1428	1428	C	658	C	649	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22686	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3560	632.2	0	.	n	.	0	T695C	SNP	695	695	T	1093	1093	C	686	C	672	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22686	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3560	632.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2036	2036	G	757	G,A	737,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22686	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3560	632.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2369	2369	C	658	C,A,T,G	633,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22686	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3560	632.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2995	2995	T	662	T,C	374,278	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22686	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3560	632.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2443	2443	A	724	A	707	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	16	blaTEM	861	245	100.0	blaTEM.l15.c4.ctg.1	245	2.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1588	folP	855	855	100.0	folP.l15.c4.ctg.1	1473	107.0	1	SNP	p	R229S	1	.	.	685	687	AGC	991	993	AGC	150;150;150	A;G;C	147;146;145	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4472	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3409	130.1	1	SNP	p	S91F	1	.	.	271	273	TTC	573	575	TTC	144;144;142	T;T;C	143;142;142	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4472	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3409	130.1	1	SNP	p	D95G	1	.	.	283	285	GGC	585	587	GGC	144;142;142	G;G;C,A	143;141;141,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4472	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3409	130.1	1	SNP	p	G95N	0	.	.	283	285	GGC	585	587	GGC	144;142;142	G;G;C,A	143;141;141,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1470	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1260	115.3	1	SNP	p	G45D	0	.	.	133	135	GGC	442	444	GGC	168;167;169	G;G;C,T	167;165;165,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	760	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	964	77.6	0	.	n	.	0	A197.	DEL	197	197	A	619	619	A	178	A	174	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3814	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2904	130.2	1	SNP	p	D86N	0	.	.	256	258	GAC	530	532	GAC	169;168;168	G;A;C,T	162;156;162,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3814	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2904	130.2	1	SNP	p	S87R	1	.	.	259	261	CGT	533	535	CGT	167;168;172	C;G,T;T	161;162,1;163	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3814	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2904	130.2	1	SNP	p	R87I	0	.	.	259	261	CGT	533	535	CGT	167;168;172	C;G,T;T	161;162,1;163	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3814	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2904	130.2	1	SNP	p	R87W	0	.	.	259	261	CGT	533	535	CGT	167;168;172	C;G,T;T	161;162,1;163	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3814	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2904	130.2	1	SNP	p	S88P	0	.	.	262	264	TCC	536	538	TCC	175;174;172	T;C;C	167;168;165	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3398	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2717	124.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1539	1541	GGC	166;165;163	G;G;C,G	161;161;155,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1291	1293	GCC	195;195;196	G;C,A;C	189;191,1;191	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1294	1296	ATG	194;191;192	A;T;G	191;188;186	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1306	1308	ACC	187;187;189	A;C;C	183;186;187	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1306	1308	ACC	187;187;189	A;C;C	183;186;187	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1807	1809	ACC	171;169;170	A,T;C;C	162,1;166;168	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1861	1863	GCG	181;181;180	G,C;C;G	179,1;179;178	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1861	1863	GCG	181;181;180	G,C;C;G	179,1;179;178	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1984	1986	GGT	130;130;129	G;G;T	123;125;122	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1993	1995	AGC	124;122;119	A;G;C	117;117;113	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3356	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2468	135.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2011	2013	CCG	94;95;94	C;C;G,C	88;89;82,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4654	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3081	150.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1670	1672	CCG	169;171;172	C;C;G	158;169;165	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2102	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1694	122.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	139	C	132	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	A251V	NONSYN	751	753	GCG	82	84	GTA	23;23;23	G;T;A	21;21;21	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	S271T	NONSYN	811	813	TCG	142	144	ACT	38;36;34	A;C;T	37;35;32	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	148	150	GAT	27;26;26	G;A;T	26;25;25	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	D276N	NONSYN	826	828	GAT	157	159	AAC	26;26;26	A;A;C	25;24;25	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	N277H	NONSYN	829	831	AAC	160	162	CAC	25;25;25	C;A;C	25;24;25	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	R307E	NONSYN	919	921	AGA	250	252	GAA	8;9;9	G;A;A	8;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	262	264	GCA	12;12;12	G;C;A	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	E312D	NONSYN	934	936	GAA	265	267	GAC	12;12;12	G;A;C	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	271	273	ATC	12;12;12	A;T;C	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	277	279	TCG	12;12;12	T;C;G	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	283	285	GCC	14;14;14	G;C;C	14;14;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	286	288	AGC	14;13;14	A;G;C	14;13;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	289	291	GCC	14;13;13	G;C;C	14;13;13	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	192	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	436	17.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	295	297	GTT	14;16;16	G;T;T	12;16;14	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2212	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1650	132.8	1	SNP	p	G120K	1	.	.	358	360	AAG	688	690	AAG	162;161;166	A,C;A;G	154,1;159;153	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2212	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1650	132.8	1	SNP	p	A121N	1	.	.	361	363	AAC	691	693	AAC	166;170;172	A;A;C,A,G	163;166;160,1,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2212	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1650	132.8	1	SNP	p	N121D	0	.	.	361	363	AAC	691	693	AAC	166;170;172	A;A;C,A,G	163;166;160,1,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8176	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5099	159.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	948	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1180	80.0	1	SNP	p	V57M	1	.	.	169	171	ATG	613	615	ATG	197;198;199	A;T;G	192;194;193	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
